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Background: There is a pressing need to identify novel antifungal drug targets to aid in the therapy of
life-threatening mycoses and overcome increasing drug resistance. Identifying specific mechanisms of action of
membrane-interacting antimicrobial drugs on the model fungus Saccharomyces cerevisiae is one avenue towards
addressing this issue. The S. cerevisiae deletion mutants Δizh2, Δizh3, Δaif1 and Δstm1 were demonstrated to be
resistant to amphibian-derived antimicrobial peptides (AMPs). The purpose of this study was to examine whether
AMPs and polyene antifungals have a similar mode of action; this was done by comparing the relative tolerance of
the mutants listed above to both classes of antifungal.
Findings: In support of previous findings on solid media it was shown that Δizh2 and Δizh3 mutants had increased
resistance to both amphotericin B (1–2 μg ml−1) and nystatin (2.5 – 5 μg ml−1) in liquid culture, after acute
exposure. However, Δaif1 and Δstm1 had wild-type levels of susceptibility to these polyenes. The generation of
reactive oxygen species (ROS) after exposure to amphotericin B was also reduced in Δizh2 and Δizh3. These data
indicated that polyene antifungal and AMPs may act via distinct mechanisms of inducing cell death in S. cerevisiae.
Conclusions: Further understanding of the mechanism(s) involved in causing cell death and the roles of IZH2 and
IZH3 in drug susceptibility may help to inform improved drug design and treatment of fungal pathogens.
Keywords: Amphotericin B, Antifungal resistance, YOL002C, AntifungalsFindings
The incidence of invasive fungal diseases is increasing,
especially in those individuals undergoing immunosup-
pressive treatments or those with predisposing conditions
[1]. The number of antifungal agents available is limited
due to the biological overlap and conserved nature of
cellular processes between fungi and mammalian cells.
Antifungal drug resistance, particularly to azoles, is also
increasing which has created a strong need for the identi-
fication of novel antifungal therapies and drug targets [2].
The major targets for antifungal drugs are the cell wall
and plasma membrane. The major groups of antifungals
in use today are the polyene (amphotericin B and nystatin)* Correspondence: o.morton@uws.edu.au
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unless otherwise stated.and azole (e.g. voriconazole) classes which target ergos-
terol in the fungal plasma membrane and ergosterol
synthesis, respectively [3]. In fungi ergosterol serves an
analogous function to cholesterol in mammalian cell
membranes and forms the basis of the selective toxicity of
many antifungals. Azoles target the proteins responsible
for ergosterol biosynthesis whereas polyenes interact with
ergosterol in the plasma membrane [4]. Resistance to
azoles has been shown to result from nucleotide polymor-
phisms is the cyp51a gene whereas resistance to polyenes
is less common due to it targeting an essential structural
component of the membrane [5]. Polyenes primarily act
by binding membrane ergosterol and forming pores in the
plasma membrane which is similar to the proposed mode
of action for antimicrobial peptides (AMPs). These are a
group of peptides that form an important part of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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defensins [6].
Detailed analysis of the activity of amphibian-derived
AMPs indicated that they induced programmed cell
death (PCD) in Saccharomyces cerevisiae [7] which was
also observed during exposure of Aspergillus fumigatus
to amphotericin B [8]. Formation of pores in membranes
is now thought to be a secondary inhibitory mechanism
for both of these classes of molecule with primary activ-
ity leading to intracellular oxidative damage and inter-
action with organelles [9]. The purpose of this study was
to build on previous research that identified S. cerevisiae
deletion mutants that were resistant to amphibian-derived
AMPs and to examine if they are also resistant to ampho-
tericin B. This may indicate similarities in the mode of
action and induction of PCD between these antifungal
agents.
The S. cerevisiae deletion mutants Δizh2, Δizh3, Δstm1
and Δaif1 were selected from the haploid yeast deletion
mutant library (strain BY4742 from Thermo Scientific)
based on the resistance of these mutants to amphibian-
derived antimicrobial peptides [7]. Cultures of these
strains and wild-type were grown in YPD broth (Sigma-
Aldrich) at 30°C with shaking at 150 rpm overnight.Figure 1 The effects of exposure to polyene antifungals on the wild-t
The effect of drug was determined by expressing each treatment as a perc
numbers between treatments and experiments. (a-b) Saccharomyces cerevi
ml−1 and 2.0 μg ml−1 for one, two and three hours. The number of viable
significantly more resistant than the wild-type and other strains tested at a
nystatin; 2.5 μg ml−1 and 5.0 μg ml−1 for one, two and three hours. The nu
and Δizh3 were significantly more resistant than the other strains after two
deviations of three replicate experiments: these were analysed by repeated
**p < 0.01, ***p < 0.001.After overnight growth cultures were adjusted to an
OD600 of 0.5 before treatment with 1–2 μg ml
−1
amphotericin B (Sigma-Aldrich) or 2.5–5 μg ml−1 of
nystatin (Sigma-Aldrich). These doses are greater than
the minimum inhibitory concentrations of the drugs
(0.1–2 μg ml−1 amphotericin B and 2.0 μg ml−1 nysta-
tin) to test drug resistance. Drug-treated cultures were
incubated for one, two and three hours after which ser-
ial dilutions of each culture were prepared and plated
onto YPD agar; these were incubated at 30°C for two
days. The plates were examined for growth and the
numbers of colony forming units (CFU) were counted.
Three independent experiments were conducted for
each treatment.
Production of reactive oxygen species (ROS) was
assessed to examine secondary effects of polyenes. Cul-
tures were treated overnight with 0.5 or 1.0 μg ml−1
amphotericin B and ROS was detected by a previously
described method using 2,7-dichlorofluorescein (Sigma
Aldrich, St Louis, MO, USA) [7].
Colony forming units (CFU) data were analysed by
repeated measures ANOVA comparing each deletion to
the wild-type and Bonferroni’s multiple comparison to
compare individual treatments. The ROS data wasype and selected deletion mutants of Saccharomyces cerevisiae.
entage of control growth to account for variations in starting cell
siae was exposed to two concentrations of amphotericin B; 1.0 μg
cells reduced over time for each strain, however Δizh2 and Δizh3 were
ll doses. (c-d) S. cerevisiae was exposed to two concentrations of
mber of viable cells reduced over time for each strain; however Δizh2
and three hour’s incubation. The data in a-d are means and standard
measures ANOVA and Bonferroni’s multiple comparison test; *p < 0.05,
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untreated cells for each strain.
Δizh2 and Δizh3 exhibit increased resistance to polyene
antifungals
Incubation of wild-type S. cerevisiae cells with increasing
doses of amphotericin B led to a reduction in viable cells
from 80% viability in the wild type (BY4742) after 1 hour
exposure at 1.0 μg ml−1 to 4% viability in the wild type
after 1 hour exposure to 2.0 μg ml−1 of amphotericin B
(Figure 1a and b). The absolute values equating to 100%
cell viability were 1 × 105 CFU ml−1 after 1 hour, 1.7 ×
105 CFU ml−1 after 2 hours and 3.7 × 105 CFU ml−1 after
3 hours. The wild type, Δaif1 and Δstm1 mutants were
highly sensitive to amphotericin B and nystatin with sig-
nificant reductions in viability over time in a dose-
dependent manner (Figure 1a-d). The Δizh2 and Δizh3
mutants showed increased resistance to exposure to
amphotericin B, which was particularly pronounced at
higher drug doses. The most pronounced differences in
drug resistance were observed when these deletion mu-
tants were exposed to amphotericin B.
Prolonged exposure to amphotericin B resulted in for-
mation of reaction oxygen species (ROS) in drug-treated
S. cerevisiae cells, all strains (Figure 2). Amphotericin B
treatment significantly increased the number of fluores-
cent cells induced in BY4742, Δaif1 and Δstm1, whereas
no significant increase was observed in Δizh2 and Δizh3.Figure 2 The effect of prolonged (24 h) exposure to
amphotericin B (0.5 μg ml−1 or 1.0 μg ml−1) on wild-type and
selected deletion mutants of S. cerevisiae measured by the
production of reactive oxygen species (ROS) within yeast cells.
Data presented are ratios of the number of fluorescent cells
compared to the total population; at least 200 cells from ten fields
of view were used to analyse each treatment. Incubation with
amphotericin B induced significantly greater production of ROS in
treated wild type BY4742, Δaif1 and Δstm1. Amphotericin B had no
significant effect on Δizh2 and Δizh3. The data shown are means
and standard deviations from three replicate experiments and were
analysed by the Manny-Whitney test to compare treated samples
with the untreated control; *p < 0.05, **p < 0.01, ***p < 0.001.ROS generation may indicate induction of PCD and cor-
relates with the oxidative damage that has been linked
to the activity of amphotericin B [10,11]. Similar data
were obtained for the reaction of S. cerevisiae and mu-
tants treated with 5.0 μg ml−1 nystatin (data not shown).
Polyene antifungals appear to cause cell death in yeast
by a distinct mechanism compared to AMPs
In this study we demonstrated that deletion of IZH2 or
IZH3 conferred increased resistance to amphotericin B,
which was previously reported for amphibian-derived
AMPs [7]. AMPs [7] and polyenes (Figure 2) lead to intra-
cellular accumulation of ROS that is associated with oxi-
dative damage and PCD. However, susceptibility of Δaif1
and Δstm1 mutants to amphotericin B suggests that a dif-
ferent mechanism may be involved in polyene-mediated
cell death. That both of these mechanisms are likely
caspase-independent in Aspergillus fumigatus [8] but not
in Candida Biofilms [12], which underlines the need to
elucidate the variety of mechanisms leading to cell death
in microbes in order to exploit these mechanisms as a
means of controlling fungal infections.
The major similarity between the two classes of antifun-
gal was the requirement for IZH2 and IZH3 for full
susceptibility of S. cerevisiae to membrane-interacting an-
tifungals. These genes are members of the progestin and
adipoQ receptor (PAQR) family, which is a group of mem-
brane embedded receptor molecules [13]. Previous studies
had shown that deletion of IZH2 and IZH3 led to resist-
ance to polyenes [14,15] and that the plant defence pro-
tein osmotin was shown to bind to Izh2p to induce PCD
[16]. The effective drug doses in this study were greater
than in the previous study which reported polyene resist-
ance in Δizh2 and Δizh3 [15]. This may be attributed to
different formulations of the drug and different culture
conditions since other studies have tested drug effects
using agar media. The proposed mechanism of action of
osmotin, a homologue of adiponectin, is to bind specific-
ally to the receptor domain of Izh2p which causes a signal
cascade that triggers PCD [17]. It is possible that the poly-
enes nystatin and amphotericin B interact with izh2p or
izh3p to induce PCD in S. cerevisiae; since the PAQR class
of proteins is widely distributed in fungi this would pro-
vide a target for rational drug design.
The direct activation of a receptor by the selected poly-
enes may not be the mechanism of action since these anti-
fungals are not structurally similar to osmotin which is a
24 kDa protein that is homologous to adiponectin [16].
The IZH family of genes has pleiotropic effects on gene
expression and their cellular roles cannot yet be function-
ally assigned to a single biochemical pathway [18,19].
Along with being involved in zinc homeostasis this gene
family is also associated with sterol metabolism [18,20].
Specifically, it is thought that their function in sterol
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ion homeostasis [19]. For example deletion of IZH3 ex-
hibits a positive genetic interaction with the genes SCS7
(sphingolipid alpha-hydroxylase) [21,22] and AUR1 (inosi-
tol phosphoceramide synthase) [23]. These are involved in
the biosynthesis of sphingolipids which are essential com-
ponents of the cell membrane. Deletion of IZH3 may
therefore alter membrane composition affecting the ability
of polyenes to bind membrane ergosterol leading to en-
hanced resistance.
This study confirms the resistance of Δizh3 and Δizh2
to polyene antifungals and indicates that Izh3p may have
functional similarities to Izh2p with regard to membrane
ergosterol content. These data also suggest that polyenes
and amphibian-derived antimicrobial peptides may in-
duce PCD in S. cerevisiae by distinct mechanisms. A full
understanding of mechanisms of cell death induced by
these antifungal agents may yield an important advance
in the development of new classes of antifungal drugs.
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